Kathleen S. Capps

Insider Reports History

Location
Watertown, MA
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen S. Capps:

Company Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Executive Director of Accounting, Controller (Principal Accounting Officer) Common Stock 8,377 $119,204 $14.23 05 Dec 2025 Direct
ENANTA PHARMACEUTICALS INC Executive Director of Accounting, Controller (Principal Accounting Officer) Stock Option (right to buy) 6,325 25 Nov 2025 Direct

Insider Reports Filed by Kathleen S. Capps

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENTA ENANTA PHARMACEUTICALS INC 05 Dec 2025 1 -$4,596 4 Executive Director of Accounting, Controller (Principal Accounting Officer) 05 Dec 2025, 18:53
ENTA ENANTA PHARMACEUTICALS INC 01 Dec 2025 2 -$4,090 4 Executive Director of Accounting, Controller (Principal Accounting Officer) 03 Dec 2025, 17:09
ENTA ENANTA PHARMACEUTICALS INC 25 Nov 2025 2 $0 4 Executive Director of Accounting, Controller (Principal Accounting Officer) 26 Nov 2025, 17:24
ENTA ENANTA PHARMACEUTICALS INC 26 Aug 2025 0 $0 3 Executive Director, Accounting & Controller; Exhibit 24 Power of Attorney filed herewith. 08 Sep 2025, 18:01